Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Biogipuzkoa (11)

2024

  1. Centenarian hippocampus displays high levels of astrocytic metallothioneins

    Aging Cell, Vol. 23, Núm. 8

  2. Dysregulated FOXO1 activity drives skeletal muscle intrinsic dysfunction in amyotrophic lateral sclerosis

    Acta Neuropathologica, Vol. 148, Núm. 1

2023

  1. Pharmacokinetic Evaluation of New Drugs Using a Multi-Labelling Approach and PET Imaging: Application to a Drug Candidate with Potential Application in Neuromuscular Disorders

    Biomedicines, Vol. 11, Núm. 2

2021

  1. Longitudinal evaluation of a novel BChE PET tracer as an early in vivo biomarker in the brain of a mouse model for Alzheimer disease

    Theranostics, Vol. 11, Núm. 13, pp. 6542-6559

  2. The skeletal muscle emerges as a new disease target in amyotrophic lateral sclerosis

    Journal of Personalized Medicine, Vol. 11, Núm. 7

2013

  1. 1–42 β-amyloid peptide requires PDK1/nPKC/Rac 1 pathway to induce neuronal death

    Translational Psychiatry, Vol. 3, Núm. 1

2012

  1. High tryptophan diet reduces CA1 intraneuronal β-amyloid in the triple transgenic mouse model of Alzheimer's disease

    Aging Cell, Vol. 11, Núm. 5, pp. 810-822

  2. Neuroglial integrity and neurodegenerative disorders

    Research Progress in Alzheimer's Disease and Dementia (V) (Nova Science Publishers, Inc.), pp. 141-172

  3. The serotonergic system in ageing and Alzheimer's disease

    Progress in Neurobiology, Vol. 99, Núm. 1, pp. 15-41

2011

  1. Early astrocytic atrophy in the entorhinal cortex of a triple transgenic animal model of Alzheimer's disease

    ASN Neuro, Vol. 3, Núm. 5, pp. 271-279

  2. Increased hippocampal CA1 density of serotonergic terminals in a triple transgenic mouse model of Alzheimer's disease: An ultrastructural study

    Cell Death and Disease, Vol. 2, Núm. 9